BioCardia (BCDA) Market Capitalization (2015 - 2026)

BioCardia (BCDA) has reported Market Capitalization for 12 consecutive years, with $15.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 39.7% year-over-year to $15.0 million in Q2 2026; TTM through Jun 2026 was $15.0 million, a 39.7% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 39.32% from the prior year.
• Market Capitalization was $15.0 million for Q2 2026 at BioCardia, up from $13.2 million in the prior quarter.
• Over five years, Market Capitalization peaked at $57.6 million in Q2 2023 and troughed at $6.0 million in Q4 2024.
• A 5-year average of $19.9 million and a median of $12.6 million in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization surged 123.83% in 2023 and tumbled 89.06% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $42.0 million in 2022, then tumbled by 62.77% to $15.6 million in 2023, then slumped by 61.71% to $6.0 million in 2024, then soared by 39.32% to $8.3 million in 2025, then surged by 79.94% to $15.0 million in 2026.
• The last three Market Capitalization figures came in at $15.0 million (Q2 2026), $13.2 million (Q1 2026), and $8.3 million (Q4 2025), per Business Quant data.